Quantity, function and genetics of HDL as an indicator of CHD.
Quantity, function and genetics of HDL as an indicator of CHD.
批准号:
07670827
负责人:
SAKU Keijiro
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Study 1 : Quantity and Function of High Density Lipoprotein as an Indicator of CoronaryAtherosclerosis Background Most of the cholesterol esterification in plasma takes place in the high density lipoprotein (HDL) fraction. The rate of cholesterol esterification in low density (LDL)-and very low density lipoprotein (VLDL)-depleted plasma, which can be expressed as the fractional esterification rate in HDL (FER_<HDL>), and which reflects the reactivity of HDL to lecithin : cholesterol acyltransferase (LCAT), is an important functional assay of HDL.The aim of the present study was to investigate the role of this functional assay of HDL in coronary atheroscierosis (CA) and to establish the best indicator for CA through the combination of quantitative and functional assays of HDL while considering conventional risk factors. Mehods and Results in a study of case and control subjects [with (CA+, n=185)/without (CA-, n=74) angiographically proven CA], we examined the association between CA and … More serum levels of HDL-cholesterol (C), HDL subfraction-C,apolipoproteins, lipoprotein (a), and FER_<HDL>. Age-and sex-adjusted values of HDL-C,HLD2-C,HLD3-C,apo A-I,and apo A-II were lower and those of lipoprotein (a) and FER_<HDL> were higher in CA+ patints than in CA-patients, but these variables were not associated with the extent of stenosis. A close negative correlation was observed between FER_<HDL> and HDL-C in both CA+ and CA- patients, but a covariance analysis indicated significant interaction between the regression line of FER_<HDL> vs. HDL-C for CA+ patients and that for CA-oatients, suggesting an altered relationship between the quantity and function of HDL in CA+ patients. A logistic regression analysis indicated that an increased odds ratio (relative risk for CA) was associated with increasing values of FER_<HDL>/HDL-C.A three-dimensional analysis of the odds ratio and values of FER_<HDL> and HDL-C indicated that patients with the highest FER_<HDL>/HDL-C value (0.68) had the highest odds ratio (12.6), but patients who had the lowest odds ratio (1.00) were those with high HDL-C and high FER_<HDL> values. The odds ratio was>10 times higher in patients with low HDL-C and middle or high FER_<HDL> values and 2.3 times higher in patients with low HDL-C and low FER_<HDL> values than in patients with high HDL-C and FER_<HDL> values, which suggests that high values of FER_<HDL> play an important role in CA,especially when HDL-C is low. Conclusion The combination of a functional assay of HDL (FER_<HDL>) with a quantitative assay of HDL (HDL-C) can be a potent indicator for caronary atherosclerosis. Less
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takata K., Saku K., Ohta T., Takata M., Bai H., Jimi S., Liu R., Sato H., Kajiyama G., Arakawa K.: "A new case of apo A-I deficiency showing codon 8 nonsense mutation of the apo A-I gene without evidence of coronary heart disease." Arterioscle Thromb Vasc
Takata K.、Saku K.、Ohta T.、Takata M.、Bai H.、Jimi S.、Liu R.、Sato H.、Kajiyama G.、Arakawa K.:“显示密码子的 apo A-I 缺陷的新病例
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamada K., Ideishi M., Nii T., Shirai K., Noguchi H., Murakami K., Noda Y., Matsuo K., Handa K,.Okabe M., Saku K., Kawaguchi H., Tanaka K., Arakawa K.: "An analysis of the patients presenting with acute myocardial infarction during a one-year period of 19
山田 K.、出井石 M.、新井 T.、白井 K.、野口 H.、村上 K.、野田 Y.、松尾 K.、半田 K、冈部 M.、佐久 K.、川口 H.、田中 K
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saku K., Zhang B., Arakawa K.: "Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits." Am J Hypertension. (in press). (1997)
Saku K.、Zhang B.、Arakawa K.:“曲格列酮可降低渡边遗传性高脂血症兔子的血压并增强胰岛素敏感性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Bai H.,Saku et al: "Polymorphism of the apolipoprotein A-IV gene and its significance in lipid metabolism and coroanry heart disease in a Japanese population." Europ J Clin Invest.26. 1115-1124 (1996)
Bai H.,Saku 等人:“载脂蛋白 A-IV 基因的多态性及其在日本人群脂质代谢和冠心病中的意义。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirata K., Saku K., Jimi S., Kikuchi S., Hamaguchi H., Arakawa K.: "Serum lipoprotein (a) concentrations and apolipoprotein (a) phenotypes in the families of NIDDM patients." Diabetologia. 38. 1434-1442 (1995)
Hirata K.、Saku K.、Jimi S.、Kikuchi S.、Hamaguchi H.、Arakawa K.:“NIDDM 患者家族的血清脂蛋白 (a) 浓度和载脂蛋白 (a) 表型。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 45 条
New diagnostic and therapeutic strategies for atherosclerosis using newly developed apolipoprotein A-I mimetic peptide
-
批准号:24591123
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2012
-
负责人:SAKU Keijiro
-
依托单位:
Possibility of drug discovery : Development of new peptide type of reconstituted HDL
-
批准号:21590960
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2009
-
负责人:SAKU Keijiro
-
依托单位:
Advanced medical technology on cardiovascular disease- Elucidation of the molecular mechanism and the application on various pathological conditions for the establishment of HDL therapy
-
批准号:18590826
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2006
-
负责人:SAKU Keijiro
-
依托单位:
Therapeutic strategy for atherosclerosis targeting for CETP
-
批准号:12670712
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:SAKU Keijiro
-
依托单位:
Quality, function and genetic assessments of NO, ACE and HDL in patients with coronary artery disease
-
批准号:09670773
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:SAKU Keijiro
-
依托单位:
HDL-apoAI gene expression and its kinetics in vivo
-
批准号:04671503
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.9万
-
财政年份:1992
-
负责人:SAKU Keijiro
-
依托单位:
HDL-apoAI and its isoproteins kinetics in rabbits and gene expressin of apoAI.
-
批准号:02671114
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1990
-
负责人:SAKU Keijiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
-
批准号:91957111
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2019
-
负责人:李佩盈
-
依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
-
批准号:81170251
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:刘梅林
-
依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
-
批准号:81070247
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:秦树存
-
依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
-
批准号:81000086
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:江立生
-
依托单位:
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
-
批准号:30971216
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:陈文强
-
依托单位:
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
-
批准号:30871040
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:陈文强
-
依托单位: